Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Raub ChristopherExecutive Vice President | Grant or award | A | — 4,179 sh | Feb 4, 2026 |
| 21 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 137.9K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Gutman CarrieSenior Vice President | Grant or award | A | — 1,620 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 21 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 2,110 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Ruppel DavidSVP & GM Transportation Bus. | Option exercise | M | — 1,113 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Ghingo John FDirector, President | Grant or award | A | — 32.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 7,031 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Honorable Colette DEVP CLO Compliance & Corp Sec | Option exercise | M | — 4,781 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Grant or award | A | — 270.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Smith NathanChief Financial Officer | Grant or award | A | — 33.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Detz Margaret MasonerChief People Officer | Grant or award | A | $125K 1,422 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Schladen JamesPresident of Arcadia | Tax withholding | F | $69K 8,053 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 20 | Koetje Todd MSee Remarks. | Grant or award | A | $193K 2,198 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Malenka Robert C.Director | Open-market sale | SELL | $127K 7,039 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Schwartz Richard ToddDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $4.35M 247.1K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 19 | France NatashaSEE REMARKS | Option exercise | M | — 10.4K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 19 | Morris Philip CDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 19 | Jones Jeanne MEVP, CFO, Audit & Risk | Disposition to issuer | D | $314K 7,154 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Duffy Kristine DDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 19 | Metzfield DennisVP, PAO & Controller | Tax withholding | F | $20K 229 sh | Feb 4, 2026 traded Jan 30, 2026 |
| 19 | Moore Alexander D.Director | Open-market sale · 10b5-1 plan | SELL | $106K 720 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Moore Alexander D.Director | Open-market sale · 10b5-1 plan | SELL | $186K 1,233 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $187K 4,064 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $378K 1,639 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 18 | Howse CurtisSee remarks | Open-market sale · 10b5-1 plan | SELL | $3.80M 52.6K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Prieskorn Laura LoueneDirector, CEO and President | Grant or award | A | — 146.5K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Malabre Richard CSVP, Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $50K 36.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Raub ChristopherExecutive Vice President | Grant or award | A | — 11.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 24.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Malenka Robert C.Director | Open-market sale | SELL | $18 1 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 17 | Cummings Don WEVP and CFO | Grant or award | A | — 14.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Bendza Gary MarkEVP, CFO | Grant or award | A | — 483.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Chelko CarrieEVP and General Counsel | Grant or award | A | — 25.9K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Gutman CarrieSenior Vice President | Grant or award | A | — 763 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 17 | Hill Donna K.VP, Human Resources | Grant or award | A | — 17.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $197K 850 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $140K 600 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Clark Kyra ESenior Vice President | Tax withholding | F | $63K 1,045 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Frost DianaDirector | Tax withholding | F | $57K 548 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Smith NathanChief Financial Officer | Tax withholding | F | $79K 3,859 sh | Feb 4, 2026 traded Feb 2, 2026 |